687 related articles for article (PubMed ID: 26530376)
1. The Role of CTCs as Tumor Biomarkers.
Lianidou ES; Markou A; Strati A
Adv Exp Med Biol; 2015; 867():341-67. PubMed ID: 26530376
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells as promising novel biomarkers in solid cancers.
Lianidou ES; Strati A; Markou A
Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
[TBL] [Abstract][Full Text] [Related]
3. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
[TBL] [Abstract][Full Text] [Related]
4. Circulating Tumour Cells in Lung Cancer.
Chemi F; Mohan S; Brady G
Recent Results Cancer Res; 2020; 215():105-125. PubMed ID: 31605226
[TBL] [Abstract][Full Text] [Related]
5. Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics.
Onstenk W; Gratama JW; Foekens JA; Sleijfer S
Cancer Treat Rev; 2013 Nov; 39(7):691-700. PubMed ID: 23683721
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells in lung cancer.
Young R; Pailler E; Billiot F; Drusch F; Barthelemy A; Oulhen M; Besse B; Soria JC; Farace F; Vielh P
Acta Cytol; 2012; 56(6):655-60. PubMed ID: 23207444
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.
O'Flaherty JD; Gray S; Richard D; Fennell D; O'Leary JJ; Blackhall FH; O'Byrne KJ
Lung Cancer; 2012 Apr; 76(1):19-25. PubMed ID: 22209049
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cells: clinical validity and utility.
Cabel L; Proudhon C; Gortais H; Loirat D; Coussy F; Pierga JY; Bidard FC
Int J Clin Oncol; 2017 Jun; 22(3):421-430. PubMed ID: 28238187
[TBL] [Abstract][Full Text] [Related]
9. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells in breast cancer--current status and perspectives.
Banys-Paluchowski M; Krawczyk N; Meier-Stiegen F; Fehm T
Crit Rev Oncol Hematol; 2016 Jan; 97():22-9. PubMed ID: 26563820
[TBL] [Abstract][Full Text] [Related]
11. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
12. In vitro expansion of tumour cells derived from blood and tumour tissue is useful to redefine personalized treatment in non-small cell lung cancer patients.
Malara NM; Givigliano F; Trunzo V; Macrina L; Raso C; Amodio N; Aprigliano S; Minniti AM; Russo V; Roveda L; Coluccio ML; Fini M; Voci P; Prati U; Di Fabrizio E; Mollace V
J Biol Regul Homeost Agents; 2014; 28(4):717-31. PubMed ID: 25620181
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications.
Tjensvoll K; Nordgård O; Smaaland R
Int J Cancer; 2014 Jan; 134(1):1-8. PubMed ID: 23447365
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells in gastrointestinal cancer.
Takeuchi H; Kitagawa Y
J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):577-82. PubMed ID: 19812887
[TBL] [Abstract][Full Text] [Related]
15. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
Chen X; Wang X; He H; Liu Z; Hu JF; Li W
PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
17. Clinical indications for, and the future of, circulating tumor cells.
Moon DH; Lindsay DP; Hong S; Wang AZ
Adv Drug Deliv Rev; 2018 Feb; 125():143-150. PubMed ID: 29626548
[TBL] [Abstract][Full Text] [Related]
18. Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer.
Bitting RL; Healy P; Halabi S; George DJ; Goodin M; Armstrong AJ
Urol Oncol; 2015 Mar; 33(3):110.e1-9. PubMed ID: 25595577
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
Lianidou ES; Markou A
Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
[TBL] [Abstract][Full Text] [Related]
20. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
